Eli Lilly and Company announced the successful completion of its acquisition of POINT Biopharma Global Inc., a radiopharmaceutical company with a pipeline of clinical...
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the...
Ever wondered what makes you, well, you? The answer lies within the complex and fascinating world of genomic sequencing. But hold on—what exactly is...
Bristol Myers Squibb and RayzeBio, Inc., announced a definitive merger agreement under which Bristol Myers Squibb will acquire RayzeBio for $62.50 per share in...
Atreca, Inc., a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune...
